| Chapter title |
Breast Cancer Survivorship: Where Are We Today?
|
|---|---|
| Chapter number | 1 |
| Book title |
Improving Outcomes for Breast Cancer Survivors
|
| Published in |
Advances in experimental medicine and biology, January 2015
|
| DOI | 10.1007/978-3-319-16366-6_1 |
| Pubmed ID | |
| Book ISBNs |
978-3-31-916365-9, 978-3-31-916366-6
|
| Authors |
Patricia A. Ganz, Pamela J. Goodwin |
| Abstract |
Breast cancer is the most common cancer in women, and survivors with this diagnosis account for almost one fourth of the over 14 million cancer survivors in the US. After several decades of basic and clinical trials research, we have learned much about the heterogeneity of breast cancer and have evolved a complex and multidisciplinary treatment approach to the disease. Increasingly, we are paying attention to the long term and late effects of breast cancer treatment, and this is largely the subject of this volume. In this chapter, the authors introduce the topic of breast cancer survivorship and highlight the organization and content of this volume, briefly describing the contents of the subsequent chapters. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 142 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 22 | 15% |
| Researcher | 21 | 15% |
| Student > Bachelor | 18 | 13% |
| Student > Ph. D. Student | 7 | 5% |
| Student > Postgraduate | 5 | 4% |
| Other | 17 | 12% |
| Unknown | 52 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 20% |
| Nursing and Health Professions | 14 | 10% |
| Biochemistry, Genetics and Molecular Biology | 13 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
| Psychology | 4 | 3% |
| Other | 18 | 13% |
| Unknown | 57 | 40% |